Leucadia National Corp bought a new stake in shares of Invacare Corporation (NYSE:IVC) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,204 shares of the health services provider’s stock, valued at approximately $161,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Northpointe Capital LLC purchased a new position in shares of Invacare Corporation during the second quarter valued at $7,724,000. Marshall Wace North America L.P. increased its position in shares of Invacare Corporation by 688.0% in the second quarter. Marshall Wace North America L.P. now owns 511,462 shares of the health services provider’s stock valued at $6,649,000 after buying an additional 446,558 shares during the period. Norges Bank purchased a new position in shares of Invacare Corporation during the fourth quarter valued at $3,143,000. Vanguard Group Inc. increased its position in shares of Invacare Corporation by 7.1% in the first quarter. Vanguard Group Inc. now owns 2,827,234 shares of the health services provider’s stock valued at $33,644,000 after buying an additional 187,697 shares during the period. Finally, Boston Partners increased its position in shares of Invacare Corporation by 116.6% in the second quarter. Boston Partners now owns 299,970 shares of the health services provider’s stock valued at $3,959,000 after buying an additional 161,500 shares during the period.

Invacare Corporation (NYSE:IVC) opened at 13.50 on Tuesday. Invacare Corporation has a 1-year low of $8.00 and a 1-year high of $16.65. The firm’s 50-day moving average is $13.96 and its 200-day moving average is $13.01. The company’s market capitalization is $443.75 million.

Invacare Corporation (NYSE:IVC) last posted its quarterly earnings results on Monday, August 7th. The health services provider reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.42) by $0.21. Invacare Corporation had a negative net margin of 6.42% and a negative return on equity of 12.79%. The business had revenue of $233.50 million during the quarter, compared to the consensus estimate of $243.03 million. During the same quarter last year, the company posted ($0.33) EPS. The firm’s revenue was down 15.1% on a year-over-year basis. Equities research analysts predict that Invacare Corporation will post ($1.87) EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Thursday, October 5th will be paid a $0.0125 dividend. This represents a $0.05 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date is Wednesday, October 4th. Invacare Corporation’s dividend payout ratio (DPR) is presently -2.59%.

COPYRIGHT VIOLATION NOTICE: This story was posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.watchlistnews.com/12204-shares-in-invacare-corporation-ivc-acquired-by-leucadia-national-corp/1529651.html.

Several research analysts have recently weighed in on IVC shares. Zacks Investment Research downgraded shares of Invacare Corporation from a “hold” rating to a “sell” rating in a research note on Friday, June 16th. ValuEngine upgraded shares of Invacare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. BidaskClub downgraded shares of Invacare Corporation from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Finally, Sidoti restated a “neutral” rating and issued a $12.00 target price (down from $14.00) on shares of Invacare Corporation in a research note on Monday, June 12th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. Invacare Corporation currently has an average rating of “Hold” and an average price target of $14.50.

About Invacare Corporation

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Institutional Ownership by Quarter for Invacare Corporation (NYSE:IVC)

Receive News & Ratings for Invacare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.